CLO26-083: Potential BMI-Dependent MACE Risk in Postmenopausal Breast Cancer Patients Treated With CDK4/6 Inhibitors: A Mayo Clinic Platform Study [0.03%]
绝经后乳腺癌患者接受CDK4/6抑制剂治疗中潜在的BMI相关心血管事件风险：一项梅奥诊所平台研究
Chenyu Sun,Yiqun Han,Abigail Fickel et al.
Chenyu Sun et al.
BIO26-047: LYZ Is a Potential Target in Preventing Progression of Chronic Gastritis to Gastric Cancer and Possibly Regulated by Hederagenin [0.03%]
BIO26-047：LYZ是预防慢性胃炎进展为胃癌的潜在治疗靶点且可能是Hederagenin的作用靶点
Pan Jinglin,Lin Zhipeng,Zhu Guanghui et al.
Pan Jinglin et al.
CLO26-132: Real-World Survival Outcomes of ALK-Rearranged Stage IV NSCLC Treated With TKIs in a Latin American Tertiary Center [0.03%]
ALK重排IV期NSCLC患者使用TKI治疗的预后因素：拉丁美洲三级医疗中心的现实世界结果(COL132)
Sofía Botero,Laura Marcela Ochoa,Manuela Estrada et al.
Sofía Botero et al.
CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast Cancer [0.03%]
TNBC的基因组调整辐射剂量（GARD）可预测总生存率的最佳放疗剂量
Shivani Nellore,Emily Ho,Nikhil Joshi et al.
Shivani Nellore et al.
CLO26-128: Efficacy and Safety of Immune Checkpoint Inhibitors in Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis [0.03%]
程序性死亡受体配体1抑制剂治疗纵隔肿瘤的疗效和安全性系统评价和 meta 分析
Gurneel Dhanesar,Canan Dirican,Bolivia Crocete Aloysia Fernandes et al.
Gurneel Dhanesar et al.
CLO26-110: Novel Targeted Therapies for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A Systematic Review [0.03%]
CLL/CNS-001：慢性淋巴细胞白血病中枢神经系统受累的新型靶向疗法系统性回顾
Abdulrahman F Al-Mashdali,Mujahid O Abdelraof,Raga M Mukhtar et al.
Abdulrahman F Al-Mashdali et al.
CLO26-094: Genomic Risk Distribution, Adjuvant Chemotherapy Trends, and Survival Outcomes in Women With pT1N0, Grade 1-2, ER/PR-Positive, LVI-Negative Breast Cancer [0.03%]
CLO26-094：pT1N0期、1-2级、ER/PR阳性、LVI阴性的乳腺癌患者的基因组风险分布、辅助化疗趋势和生存结果
Nickolas Stabellini,Maya Lubarsky,Amanda L Amin et al.
Nickolas Stabellini et al.
CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review [0.03%]
中枢神经系统受累慢性淋巴细胞性白血病的鞘内注射利妥昔单抗：病例报告及文献回顾
Aashima Gupta,Mina Aiad,Yacoub Faroun
Aashima Gupta
CLO26-080: Impact of Cancer Related Distress Estimated by Distress Thermometer on Cerebral Glucose Metabolism and Impact on Chemotherapy Response in Lymphoma Patients [0.03%]
DLBCL患者的癌症相关焦虑对脑葡萄糖代谢的影响及对化疗疗效的影响研究
Nosheen Fatima,Maseeh Uz Zaman,Anas Muhammad et al.
Nosheen Fatima et al.
BPI26-008: Optimizing Germline Genetic Referral and Testing Rates for High-Grade Serous Ovarian Cancer Patients [0.03%]
优化高分级浆液性卵巢癌患者的遗传咨询和检测率（BPI26-008）
Terra Warner,Amy Laughlin,Heather Owen et al.
Terra Warner et al.